Table 2.
HBV prevalence in different genders and age groups in fixed cohort
Groups | Group size | Round 1 | Round 2 | ||||
---|---|---|---|---|---|---|---|
No. of HBsAg positive | HBsAg positive rate(%) | 95% CI(%) | No. of HBsAg positive | HBsAg positive rate(%) | 95% CI(%) | ||
25–29 | 11 | 3 | 27.3 | −4.1–58.7 | 3 | 27.3 | −4.1–58.7 |
30–34 | 70 | 15 | 21.4 | 11.6–31.3 | 16 | 22.9 | 12.8–32.9 |
35–39 | 107 | 8 | 7.5 | 2.4–12.5 | 7 | 6.5 | 1.8–11.3 |
40–44 | 254 | 37 | 14.6 | 10.2–18.9 | 36 | 14.2 | 9.9–18.5 |
45–49 | 545 | 56 | 10.3 | 7.7–12.8 | 67 | 12.3 | 9.5–15.1 |
50–54 | 683 | 61 | 8.9 | 6.8–11.1 | 79 | 11.6 | 9.2–14.0 |
55–59 | 663 | 57 | 8.6 | 6.5–10.7 | 76 | 11.5 | 9.0–13.9 |
60–64 | 887 | 71 | 8.0 | 6.2–9.8 | 86 | 9.7 | 7.7–11.6 |
65–69 | 949 | 57 | 6.0 | 4.5–7.5 | 57 | 6.0 | 4.5–7.5 |
70–74 | 643 | 44 | 6.8 | 4.9–8.8 | 39 | 6.1 | 4.5–7.9 |
75–79 | 518 | 24 | 4.6 | 2.8–6.4 | 19 | 3.7 | 2.0–5.3 |
>80 | 1047 | 37 | 3.5 | 2.4–4.7 | 34 | 3.2 | 2.2–4.3 |
All | 6377 | 470 | 7.4 | 6.7–8.0 | 519 | 8.1 | 7.5–8.8 |